Current positions

Nathan Nagel: Current Positions

(1) CEO of the Fratrem Group Ltd

The Fratrem Group has successfully operated for over 10-years in the UK, EU, USA, and the Middle East. The group is comprised of 4 organisations

Nathan Nagel

(2) Board member at Quest Prehabilitation 

Telehealth cancer and surgical prehabilitation service

(3) Board member at Digistain 

Breast cancer diagnostics  

(4) Faculty at Barts X Medicine digital health program

The first digital health and business programme in England to be integrated into the medical curriculum, to improve medical teaching.

(5) Mentor to founders on the Cancer Tech Accelerator

Cancer Research UK and Capital Enterprise, together with Roche UK, launched the Cancer Tech Accelerator programme to support innovative technologies to advance early detection, diagnosis, monitoring, and treatment of cancer.

An Influencer on LinkedIn

Nathan has been a leader of multiple highly successful LinkedIn groups for the last 10 years. He has over  30K connections and 50K members in his groups.

 

LINKEDIN GROUPS

DUE DILIGENCE

To undertake DD on Nathan Nagel, view his Companies House data here 

PAST POSITIONS

  • CEO Gamlen Tableting Ltd – Global pharmaceutical compaction analysis equipment company.
  • Managing Director Sanyal Bio LLC – Global contract research organization for metabolic disease.
  • CEO Neuro-Bio Ltd – Oxford University Neuroscience biotechnology spin-out.
  • CEO Oncology Pharma Ltd – International oncology pharmaceutical market intelligence company.
  • Managing partner LifeScience Ventures Ltd – Healthcare Venture Capital Advisory.
  • Senior Sales and Marketing – Bayer Diagnostics.
  • Sales and marketing – Takeda Pharmaceuticals.
  • Door-to-door sales representative selling a wide variety of goods.

Contact Nathan to open a discussion with him.